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Objective/background: Microbial infections such as tuberculosis is a major cause of mortality
worldwide. Plant-derived phytochemicals have a long history of providing much-needed
novel therapeutics. Triterpenoids are among the prominent phytochemicals that possess
numerous biological activities. Among them is maslinic acid (MA), a biologically active
olean-type pentacyclic triterpenoid. In search of a novel antimicrobial agent, we aimed
to evaluate the antimicrobial potential of MA.
Methods: Antibacterial and antifungal activity was evaluated through the agar well diffu-
sion method. Antitubercular activity was analysed through the agar well diffusion and disc
diffusion methods, respectively. Antioxidant capacity was determined through assays for
total antioxidant capacity, 2,2-diphenyl-1-picrylhydrazyl radical scavenging, hydrogen per-
oxide radical scavenging, and Fe3+ reducing power. The program Prediction of Activity
Spectra for Substances was used to calculate the possible biological activity of MA.
Results: MA showed dose-dependent antioxidant activity similar to that of ascorbic acid. It
had no inhibitory effect on bacterial strains, but it had moderate activity against the fungi
Aspergillus flavus and Ustilago maydis, with Aspergillus niger being the most sensitive to MA.
MA also exhibited strong antimycobacterial activity. Probable antioxidant, antibacterial,
and antifungal activity of MA based on software calculations are 0.479, 0.363 and 0.589
respectively.
Conclusion: This work provides scientific evidence of the antioxidant, antifungal, and
antimycobacterial activities of MA, showing its potential application in the development
of natural antioxidants and antimicrobial agents for the agro-food and pharmaceutical
industries.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).niversity,
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The increasing availability of life-saving drugs such as antibi-
otics has led to advances in the developedmedicalworld. How-
ever, extensive use of these synthetic drugs has led to life-
threatening side effects and development of resistant strains
of deadly pathogenic microorganisms [1,2]. Development of
novel antimicrobial drugs that overcome these problems is
therefore a major challenge for pharmaceutical industries.
Plant-derived antimicrobials and antioxidants have a long
history of providingmuch-needed safe and novel therapeutics
[3–5]. Plants constantly interact with rapidly changing and
potentially damaging external environmental factors such as
microbial attack and oxidative stress. This interaction involves
alternative defence strategies, including synthesis of a wide
variety of chemical metabolites that counter these stressors.
According to the World Health Organization, medicinal plants
are the best source of various biologically active drugs [2]. To
date, only 10–15% of plant species have been explored for their
therapeutic potential for various ailments [6].
Free radicals generated during various metabolic pro-
cesses affect multiple functions such as defence against
infections and cancers [7,8]. Enzymatic and nonenzymatic
defence systems within the body neutralise these free radi-
cals by balancing their oxidation and reduction reactions.
Under certain conditions such as infections, which induce
oxidative stress, free radicals overwhelm this balance and
exacerbate the adverse effects of such diseases [9]. The liter-
ature indicates that use of phytochemicals with antioxidant
and antimicrobial potential are associated with a low risk of
mortality and sepsis [3].
Triterpenes, secondary metabolites of isopentenyl
pyrophosphate oligomers, constitute a large group of phyto-
constituents. More than 20,000 natural triterpenoids are
known, someofwhich exist in free formand some in combina-
tion with other constituents [10]. Most of them are present in
plants suchas seaweed, andsomearepart of thewax-like coat-
ings of numerous fruits andmedicinal herbs [11]. Maslinic acid
(MA) is an olean-type pentacyclic triterpenoid that is struc-
turally similar to oleanolic acid, a pentacyclic triterpenoid. It
possesses activity against type-2 diabetes [12], malaria [13],
and cancer [14]. Oleanolic acid is a potentially hepatoprotec-
tive, anti-inflammatory, antioxidant, anticancer, antitubercu-
lar agent [15–17]. Therefore, it is of interest to evaluate the
biological activities ofMA against common human pathogens.
Materials and methods
Collection of MA
A MA-rich alcoholic fraction of leaves of the plant Eriobotrya
japonica was obtained from 3W Botanical Extract (batch no
LLPE-111227, China).
Reagents and chemicals
Analytical-grade dimethylsulphoxide (DMSO), methanol,
sodium hydroxide, hydrogen peroxide, and potassiumdihydrogen phosphate were obtained from Rankem (Mumbai,
India). 2,2-Diphenyl-1-picrylhydrazyl (DPPH), nutrient agar,
potato dextrose agar, and yeast potato dextrose agar were
purchased from Himedia (Mumbai, India). Ascorbic acid was
obtained from Oxford Laboratory (Mumbai, India).
Test microorganisms
The MA-rich fraction was tested against four bacterial strains,
namely, Pseudomonas aeruginosa CC 488, Bacillus subtilis B 28,
Bacillus megaterium, and Escherichia coli MTCC 170. Fungal
strains selected for antifungal experiments were Aspergillus
flavus MTTC 873, Ustilago maydis NCIM 983, Aspergillus niger
MTCC A, Aspergillus fumigates MTCC 2551, Saccharomyces cere-
visiae MCIM 170, and Candida albicans MTCC 3018. All strains
were obtained from the School of Life Sciences at Swami
Ramanand Teerth Marathwada University (Nanded, India).
Three species of Mycobacterium, namely, Mycobacterium tuber-
culosis, Mycobacterium phlei, and Mycobacterium smegmatis,
were procured from the Microbial Type Culture Collection
and the gene bank at the Institutes of Microbial Technology
(Chandigarh, India).
Antioxidant activity
Total antioxidant capacity
The total antioxidant capacity of MA was calculated through
the total antioxidant capacity assay. MA and ascorbic acid
solutions in DMSO at concentrations ranging from 20 lg/mL
to 100 lg/mL were prepared. The reagent solution (3 mL of a
0.6 M sulphuric acid/28 mM sodium phosphate/4 mM ammo-
niummolybdatemixture)wasmixedwith 0.30 mLof thework-
ing standards. The reaction mixture was incubated for 90 min
at 95 C and then cooled to room temperature. Absorbance at
695 nm was measured against the blank, DMSO, and ascorbic
acidwas used as the standard. All testswereperformed in trip-
licate. The total antioxidant capacity was expressed in terms
of equivalents of ascorbic acid. The antioxidant capacity of
MA was expressed in terms of the absorbance: a high
absorbance represents high antioxidant activity [18,19].
DPPH radical scavenging activity
The radical scavenging potential of MA was evaluated in
terms of its activity in DPPH radical scavenging according to
the method of Sun et al. [19]. Selected concentrations
(20–100 lg/mL) of working standards of MA and ascorbic acid,
as well as a 0.1 mM solution of DPPH in methanol, were
prepared. A 1 mL aliquot of the DPPH solution was
added to 2 mL of the MA solution at different concentra-
tions (20 mg/mL, 40 mg/mL, 60 mg/mL, 80 mg/mL, and
100 mg/mL). Eachmixture was shaken vigorously and allowed
to stand in the dark at room temperature for 30 min. The
control solution contained all reagents except MA, and the
blank was DMSO. The absorbance of each mixture was mea-
sured spectrophotometrically at 517 nm (UV-1800 UV–VIS
spectrophotometer, Shimadzu). The percentage of the activity
of MA in DPPH radical scavenging was calculated through the
formula:
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where At is the absorbance of MA and A0 is the absorbance of
the control. The antioxidant activity was evaluated as IC50,
which is the MA concentration required to scavenge 50% of
DPPH free radicals.
Hydrogen peroxide radical scavenging activity of MA
The H2O2 scavenging assay was performed to evaluate the
ability of MA to scavenge hydrogen peroxide radicals. A
40 mM H2O2 solution in pH 7.4 phosphate buffer was pre-
pared. Solutions of MA in distilled water (1 mL) at different
concentrations (50 lg/mL, 100 lg/mL, 150 lg/mL, 200 lg/mL,
and 250 lg/mL) was added to 0.6 mL of hydrogen peroxide
solution. The absorbance of eachmixture at 230 nmwasmea-
sured using a Shimadzu UV-1800 UV–VIS spectrophotometer
against a blank solution containing phosphate buffer solution
without hydrogen peroxide. At and A0 for MAwere then deter-
mined [20,21]. The IC50 value, which is the sample concentra-
tion at which scavenging activity is 50%, was also determined.
The percentage of H2O2 scavenging activity of MA and ascor-
bic acid was calculated through the equation, Percentage of
scavenging activity (%) = (1  At/Ao)  100.
Reducing power of MA and ascorbic acid
The reducing power of MA and ascorbic acid was resolved by
using a modification of the methods described by Liu et al.
[18] and Sun et al. [19]. MA solutions in DMSO at concentra-
tions of 50–250 lg/mL were prepared. A 0.13-mL MA sample
at each concentration was added to 0.125 mL of phosphate
buffer (0.2 M, pH 6.6) and 0.125 mL of potassium ferricyanide
(1%, w/v). This mixture was incubated for 20 min at 50 C,
and then 0.125 mL of trichloroacetic acid solution (10%, w/v)
was added to complete the reaction. A ferric chloride solution
(1.5 mL; 0.1%, w/v) was added to the mixture, and the absor-
bance at 700 nm was measured against the blank, DMSO.
Ascorbic acid was used as the standard. The reducing ability
of the mixture was calculated by observing the absorbance
of the reaction mixture, that is, an increase in its absorbance
indicates an increase in its reducing ability.In vitro antimicrobial assay
Antibacterial and antifungal activity of MA
The antibacterial and antifungal activity of MAwas evaluated
through the agar-well diffusion method with modifications.
Sterile nutrient agar was poured into sterile standard Petri
plates (20 mL) and then allowed to congeal. The plates were
inoculated with 100 lL of the microbial culture by spread-
plate technique. By using a sterile borer, four wells were
punched. For the antibacterial activity experiments, samples
of 100 lg/mL MA solutions, the standards (ciprofloxacin and
amoxicillin), and the solvent (DMSO) were loaded into respec-
tive wells, and then the Petri plates were incubated at 37 C
for 24 h. Incubation was done at 34 C for 48 h for the antifun-
gal activity experiments. The inhibition zone that appeared
around each well, which represents the antibacterial poten-
tial of samples, was measured by using a zone reader scale
[22].Antimycobacterial activity of MA
The antimycobacterial potential of MA was determined by
agar-well diffusion and disc diffusion methods.
Well diffusion method
A modification of the agar well diffusion method by Dahech
et al. [22] was performed to evaluate the antimycobacterial
activity. Middlebrook 7H11 agar with 0.1 mL of mycobacterial
culture was spread and then incubated at 37 C. Wells with
0.5 cm diameter were punched by using a sterile cork borer.
A MA solution (50 lL, 50 mg/mL) and rifampicin were loaded
into the respective wells, which were then incubated at 37 C
for specific periods (M. smegmatis: 1 day; M. phlei: 5 days;
M. tuberculosis: 3 weeks). The diameter of the inhibition zone
was observed after the incubation period and then measured
by using a zone reader scale.
Disc diffusion method
The antimycobacterial activity of MA was analysed through
the disc diffusion method. The mycobacterium inoculum
was adjusted to the required concentration (approximately
1.2  108 CFU/mL). A 100 lL aliquot of inoculum was spread
on the surface of an agar plate by using a sterile cotton-
tipped swab to form an even layer. A paper disc (6 mm
diameter) was impregnated with a dilute rifampicin solution
(5 lg/disc) and then allowed to dry for 30 min. It was then
placed on the surface of each plate by using a sterile pair of
forceps. Similarly, MA was prepared and placed. The plates
were incubated under aerobic conditions for specific periods
(M. smegmatis: 1 day; M. phlei: 5 days; M. tuberculosis: 3 weeks)
at 37 C, and then the diameter of inhibition zone was
measured by using a zone reader scale [23–25].
Determination of minimum inhibitory concentration and
minimum microbicidal concentration
Each strain that produced an inhibition zone was tested for
minimum inhibitory concentration (MIC) through serial dilu-
tion of MA. The MIC for antifungal activity was determined
through the broth dilution method of Ye et al. [26]. Solutions
of MA at different concentrations (50–150 lg/mL) were pre-
pared. Nutrient broth (2 mL) was mixed with 0.5 mL of MA
solution, and a loopful of each test microorganism was added
to the test tube, which was then incubated for 28 h. The MIC,
the lowest MA concentration at which the test microorgan-
isms did not demonstrate any visible growth, was then deter-
mined. Clear solutions in the test tubes (i.e., those with no
turbidity) were streaked on nutrient agar medium and then
incubated for 28 h at 28 C. The lowest MA concentration used
with the medium having colonies fewer than five was taken
as the minimum microbicidal concentration.
The MIC of MA for antitubercular activity was determined
by using the well diffusion and disc diffusion methods.
Strains producing inhibition zones were tested for MIC. MA
solutions with the required concentrations (2–10 mg) were
prepared. Five to six wells were punched into the agar med-
ium. Each well was loaded with each MA solution and incu-
bated for a specified period at 37 C. In the disc diffusion
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more than 6 mm diameter was taken as the MIC according
to the standards of the Clinical and Laboratory Standard
Institute [24].
In silico prediction using PASS
PASS (Prediction of Activity Spectra for Substances), a
computer-based program, was used to screen the antimicro-
bial and antioxidant potential of MA. The software predicts
biological activities of chemical structures, including those
of phytochemicals, on the basis of structure–activity relation-
ship with a known chemical entity. It predicts the desirable
pharmacological effect, as well as molecular mechanisms of
action and unwanted side effects such as mutagenicity, car-
cinogenicity, teratogenicity, and embryotoxicity [27]. It com-
pares the structure with a training set containing more than
205,000 compounds exhibiting more than 3750 kinds of bio-
logical activity. The activity is estimated in terms of Pa (prob-
able activity) and Pi (probable inactivity). Structures with Pa
greater than Pi were the only compounds considered for a
particular pharmacological activity [28,29].
Statistical analysis
All data are presented as mean ± standard error of the mean.
Results were evaluated by one-way analysis of variance fol-
lowed by Tukey’s test using Graphpad Prism (version 6, USA)
and Graphpad Instat (version 3.0.1, USA) software. IC50 values
for antioxidant activity were calculated by linear regression
analysis of three measurements. The difference was consid-
ered to be statistically significant if p < .05.
Results
Antioxidant activity
Total antioxidant capacity
The total antioxidant activity of MA was determined through
the phosphomolybdenum method. Reduction of Mo(IV) to
Mo(V) and green phosphate/molybdenum(V) compounds by
antioxidants present in the sample at low pH results in an
absorption peak at 695 nm, which can be used to evaluate
the antioxidant capacity. The dose-dependent increase
(Fig. 1A) in absorbance values indicates that MA possesses
substantial antioxidant activity, similar to the standard,
ascorbic acid. IC50 values of MA and ascorbic acid were found
to be 153.81 and 103.30 lg/mL, respectively (Table 1).
Activity in DPPH radical scavenging
An assay for activity in DPPH radical scavenging was used to
determine the ability of MA to scavenge reactive species by
donating hydrogen (Fig. 1B). The odd electron in DPPH has
an ultraviolet–visible absorption maximum at 517 nm. This
electron becomes paired off in presence of a hydrogen donor,
a free-radical scavenging antioxidant. The decrease in absor-
bance is thus considered a measure of the antioxidant
activity. Percentages of the scavenging activity of MA at
20 lg/mL, 40 lg/mL, 60 lg/mL, 80 lg/mL, and 100 lg/mL were31.408 ± 0.12%, 36.765 ± 0.16%, 40.021 ± 0.06%, 43.873 ± 0.21%,
and 46.254 ± 0.12%, respectively, indicating a concentration-
dependent increase in the radical scavenging ability similar
to that of ascorbic acid. The scavenging ability of MA, mea-
sured in terms of the IC50 (the concentration resulting in
50% inhibition; Table 1), was found to be 116.20 lg/mL.
Activity in H2O2 radical scavenging
The ability of MA to scavenge hydrogen peroxide, depicted in
Fig. 1C, was compared with that of the reference standard,
ascorbic acid. MA demonstrated activity in scavenging
hydrogen peroxide radicals in a dose-dependent manner. Per-
centages of inhibition of hydroxyl radical scavenging by MA
are 37.67 ± 0.01%, 57.97 ± 0.01%, 63.83 ± 0.01%, 79.82 ± 0.01%
and 80.37 ± 0.01% at MA concentrations of 50 mg/mL,
100 mg/mL, 150 mg/mL, 200 mg/mL, and 250 mg/mL, respec-
tively. These results show that an increase in MA concentra-
tion leads to a corresponding increase in the scavenging
rate. Similarly, dose-dependent scavenging was observed
with ascorbic acid (Fig. 1C). IC50 values for MA and ascorbic
acid are 85.03 and 61.06 lg/mL, respectively (Table 1).
Assay of the Fe3+ reducing power
We determined the ability of MA and ascorbic acid to reduce a
ferric ion/ferricyanide complex to the ferrous form via elec-
tron donation. The reducing power of MA was 0.606 ± 0.001,
0.655 ± 0.001, 0.087 ± 0.001, 1.268 ± 0.008, and 1.581 ± 0.001
at concentrations of 50 mg/mL, 100 mg/mL, 150 mg/mL,
200 mg/mL, and 250 mg/mL, respectively; whereas at the
same concentrations, that of ascorbic acid was 0.809 ± 0.005,
0.701 ± 0.008, 1.401 ± 0.042, 1.846 ± 0.022 and 2.170 ± 0.103,
respectively. Therefore, MA showed dose-dependent reducing
power similar to that of ascorbic acid (Fig. 1D).
Antimicrobial activity
Antibacterial and antifungal activity
The antimicrobial potential of MA was estimated by using
four bacterial strains and six fungal strains. Results for the
antibacterial activity experiment (Table 2) suggest that MA
is completely inactive against all of the tested bacterial
strains. MA produced no zone of inhibition, while standard
ciprofloxacin and amoxicillin showed potent antibacterial
activity against all of the strains (Table 2).
The antifungal activity of MA and clotrimazole are indi-
cated in Table 3. MA exhibited potent activity against A. niger
(8.16 ± 0.44), similar to that of clotrimazole (10.33 ± 0.33),
whereas A. flavus (4.33 ± 0.33) and U. maydis (3.66 ± 0.33) mod-
erately reduced growth. MA was found to be ineffective
against S. cerevisiae, C. albicans, and A. fumigates.
MIC and minimum microbicidal concentration
MA exhibited no activity against all tested bacterial strains in
the agar well diffusion method. However, the antimicrobial
activity of MAvaried with the microbial species. MA produced
an inhibition zone around A. flavus, U. maydis and A. niger.
Thus, the MIC and minimum fungicidal concentration (MFC)
of MA (Table 3) confirm its antifungal activity in the broth dilu-
tion method. MICs of MA for the tested fungi range from
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Fig. 1 – Antioxidant activities of maslinic acid evaluated by using in vitro antioxidant models: (A) total antioxidant capacity;
(B) DPPH radical scavenging activity; (C) H2O2 radical scavenging activity; and (D) Fe
3+ reducing power assay. Each value
represents mean ± standard error of the mean (n = 3). Note: DPPH = 2,2-diphenyl-1-picrylhydrazyl.
Table 1 – IC50 values of MA and ascorbic acid.
a
Sr. No. Antioxidant assay/method IC50 (lg/mL)
MA Ascorbic acid
1 Total antioxidant capacity 153.81 103.30
2 DPPH radical scavenging activity 116.20 52.62
3 H2O2 radical scavenging activity 61.06 85.03
Note: DPPH = 2,2-diphenyl-1-picrylhydrazyl; IC50 = half maximal inhibitory concentration; MA = maslinic acid.
a IC50 values were calculated by linear regression analysis of three measurements.
Table 2 – Activity of MA, DMSO, and standard antibiotics against bacterial strains tested through the agar well diffusion
method.
Bacterial species Diameter of inhibition zone (mm)
MA DMSO Standard antibiotic
Amoxicillin Ciprofloxacin
Bacillus megaterium — — 8 15
Bacillus subtilis — — 11 14
Escherichia coli — — 9 11
Pseudomonas aeruginosa — — 10 18
Note: DMSO = dimethyl sulphoxide; MA = maslinic acid.
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Table 3 – MIC andMFC of MA and the activity of MA, DMSO, and standard antibiotics against fungal strains tested through the
agar well diffusion method.
Fungal species Diameter of inhibition zone (mm) MA
MA DMSO Clotrimazole MIC (lg/mL) MFC (lg/mL)
Aspergillus flavus 4.33 ± 0.33 — 7.33 ± 0.88 90 ± 5.77 103.33 ± 3.33
Ustilago maydis 3.66 ± 0.33 — 6.33 ± 0.33 86.66 ± 3.33 103.33 ± 3.33
Aspergillus niger 8.16 ± 0.44 — 10.33 ± 0.33 96.66 ± 3.33 106.66 ± 3.33
Aspergillus fumigates — — — — —
Candida albicans — — — — —
Saccharomyces cerevisiae — — — — —
Note: DMSO = dimethyl sulphoxide; MA = maslinic acid; MFC = minimum fungicidal concentration; MIC = minimum inhibitory concentration.
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to 106.66 lg/mL.
Antimycobacterial activity
MAwas analysed for its activity againstM. phlei,M. smegmatis,
and M. tuberculosis through the disc diffusion and well diffu-
sion methods. Calculation results were expressed as MICs in
lg/mL (Table 4). In the disc diffusion method, MA exhibited
inhibitory effect againstM. smegmatis,M. phlei, andM. tubercu-
losis (Fig. 2A–C), producing inhibition zones with diameters of
4.33 ± 0.33, 8 ± 1.15, and 5.66 ± 0.33 mm, respectively. MICs of
MA for M. phlei and M. tuberculosis are 4.96 ± 0.08 lg/mL and
2.50 ± 0.05 lg/mL, respectively.
Similarly, MA produced inhibition zones around
M. smegmatis,M. phlei, andM. tuberculosis (Fig. 2D–F) in thewell
diffusion method. MA showed activity against M. smegmatis,
M. phlei, andM. tuberculosis, giving inhibition zoneswith diam-
eters of 8 ± 1.15, 7 ± 0.57, and 6.3333 ± 0.33 mm, respectively.
MA had an MIC (Table 5) of 2.56 ± 0.03 lg/mL for M. phlei and
2.53 ± 0.03 lg/mL forM. tuberculosis.
PASS calculations for antioxidant, antibacterial, and
antifungal activities
The biological activity spectra of MAwas determined by using
an online version of PASS software. The results obtained
(Table 6) were interpreted and used in a flexible manner. MA
showed the highest Pa for antifungal activity (0.589), and its
Pa values for antioxidant and antibacterial activity are 0.479
and 0.363, respectively.Table 4 – Antitubercular activity and MIC of MA in the disc diffu
Mycobacterium species Diameter of inhibitio
MA
Mycobacterium smegmatis 8 ± 1.15
Mycobacterium phlei 4.33 ± 0.33
Mycobacterium tuberculosis 5.66 ± 0.33
Note: MA =maslinic acid; MIC = minimum inhibitory concentration.Discussion
The rapid development of mutants and resistant pathogenic
strains is a major reason for the failure of synthetic antibi-
otics [30]. The constant exposure of plants to diverse environ-
mental changes and stress conditions causes the plants to
synthesise metabolites that protect them from these unfa-
vourable situations [2]. Free radicals generated during normal
metabolism of cells contribute to immunity from pathogenic
infections. Generation of these radicals is primarily regulated
by the antioxidant system, which acts through diverse mech-
anisms such as inhibition of chain initiation, binding of
transition-metal ion catalysts, and scavenging of radicals
[8,31]. Certain conditions associated with stress, such as
infections, contribute to the formation of free radicals, thus
disturbing its balance. This imbalance, in turn, disrupts cellu-
lar components such the cell membrane, mitochondria,
nuclear components, as well as macromolecules. It also leads
to aging, vital-organ damage, neurodegenerative complica-
tions, diabetes mellitus, and other diseases [32,33]. Bacterial
and fungal infections perturb the balance of oxidation and
reduction processes, exacerbating oxidative stress [34,35].
Such oxidative effects hasten disease progression, which
can be delayed by proper use of antioxidants [9].
Olean-type pentacyclic triterpenoids are transcriptional
regulators of antioxidants and detoxifying enzymes.
Oleanolic acid has ability to scavenge reactive oxygen free
radicals by direct chemical reactions. The mechanism for this
potent antioxidant property is the increase in Nuclear
factor-erythroid 2-related factor (Nrf2)-mediated expression
of antioxidant enzymes such as catalase and thioredoxinsion method.
n zone (mm) MA
Rifampicin MIC (lg/mL)
24 ± 0.66 —
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Fig. 2 – Activity of maslinic acid (MA) and rifampicin (R) against Mycobacterium smegmatis, Mycobacterium phlei, and
Mycobacterium tuberculosis using the (A–C) disc diffusion method and (D–F) well diffusion method.
Table 6 – Results of PASS calculations for antioxidant, antibacterial and antifungal activity of MA.
Activity PASS predictions of MA
Pa Pi
Antioxidant 0.479 0.008
Antibacterial 0.363 0.037
Antifungal 0.589 0.020
Chitinase inhibitor 0.831 0.002
Membrane integrity antagonist 0.934 0.001
Note: MA =maslinic acid; Pa = probable activity; PASS = Prediction of Activity Spectra for Substances; Pi = probable inactivity.
Table 5 – Antitubercular activity and MIC of MA in the well diffusion method.
Mycobacterium species Diameter of inhibition zone (mm) MA
MA Rifampicin MIC (lg/mL)
Mycobacterium smegmatis 8 ± 1.15 26 ± 0.57 —
Mycobacterium phlei 7 ± 0.57 25 ± 0.57 2.56 ± 0.03
Mycobacterium tuberculosis 6.33 ± 0.33 25 ± 0.57 2.53 ± 0.03
Note: MA =maslinic acid; MIC = minimum inhibitory concentration.
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antioxidant glutathione [12]. MA is an olean-type pentacyclic
triterpenoid that has been studied for its antioxidant poten-
tial, in particular, activity in DPPH radical and hydrogen per-
oxide radical scavenging, total antioxidant activity, and Fe3+
reducing power. The free radicals DPPH and hydrogen perox-
ide possess absorbance maxima at particular wavelengths.
Scavenging or complexation of these radicals by radical scav-
engers decreases concentrations of radicals, which induce
oxidative stress [19]. MA showed dose-dependent, moderate
neutralisation of DPPH radicals. H2O2 is involved in theformation of reactive oxygen species such as superoxide
anion radicals and hydroxyl radicals [18]. MA was found to
scavenge hydrogen peroxide free radicals as effectively ascor-
bic acid does. The total antioxidant assay, which reflects the
antioxidant capacity of the nonenzymatic defence system
[18], showed high values for the reaction mixture, thus imply-
ing the strong total antioxidant activity of MA. MA shows
antioxidant activity by donating an electron, forming a fer-
rous complex in a dose-dependent manner. This effect is
due to the reducing tendency of the compounds due to its
capacity to break the free radical chain reaction by donating
424 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 5 ( 2 0 1 6 ) 4 1 7 –4 2 5hydrogen [36]. Although the antioxidant activity of MA varied
in the antioxidant assay, it was close to that of ascorbic acid,
indicating its strong antioxidant potential.
Since ancient times, secondary metabolites of plants have
been known for their medicinal properties [23]. Many compre-
hensive reports indicate the antibacterial, antifungal, antiox-
idant, antiviral and antihelminthic properties of plants
[24,25,37]. Pentacyclic triterpenoids, in particular, have an
extensive range of biological activity [10]. In search of an
effective antimicrobial agent, we focused on MA in the pre-
sent study. MAwas not effective against the tested pathogenic
bacterial strains, but it produced a clear inhibition zone
around all of the tested Mycobacterium strains. Triterpenoids
such as ursolic acid and oleanolic acid possess strong antimy-
cobacterial activity, damaging the bacterial complex cell
envelope (antilipidic activity) and the immunoregulatory
mechanism mediated by nitric oxide and TNFa (tumor necro-
sis factor) synthesis [38]. Such mechanisms seem to partly
explain the strong antimycobacterial activity of MA. Whereas
MA exhibited moderate antifungal activity, its effect on A.
niger was prominent, as showing by its clear inhibition zone.
A. niger is much more resistant to various biocides than are
pathogenic strains of Gram-positive and -negative bacteria
[39]. Therefore, MAmay be the best treatment for the effective
management of Aspergillus-associated infections.
Calculations using PASS software have been used exten-
sively to confirm and correlate biological activities of chemi-
cals [28,29]. Our results are confirmed by a structural study
of MA using the software, which works on the principle of
structure-based comparison of MA with existing antimy-
cobacterial compounds. The Pa value of MA for antifungal
activity is higher than those for antibacterial and antioxidant
activity. As the fungal cell wall contains compounds such as
mannan, chitin, and glucans, which are unique to fungi [40],
the calculation results suggest that MA is a chitinase inhibitor
(Pa, 0.831) and that it is an antifungal agent. Membrane integ-
rity, an indicator of the viability of microorganisms [41], was
also apparently disrupted by MA (Pa, 0.934). Thus, MA may
be an antimicrobial compound. Thus, the chitinase inhibition
and disruption of membrane integrity could contribute to the
antimicrobial effects of MA.
To date, very few studies comprehensively describe the
antimicrobial profile of triterpenoids from medicinal plants.
Our study is the first to explore the in vitro antioxidant and
antimicrobial properties of triterpenoids using software. The
study showed variable effects of MA on bacterial and fungal
strains, as well as potent inhibitory effects against mycobac-
terial strains. Therefore, MA is a potential candidate com-
pound for the treatment of tuberculosis and fungal infection.
Conclusion
Our study showed that MA is a biologically active triterpenoid
that exhibits mild antioxidant and antifungal activity. The
antioxidant property can ameliorate oxidative damage
induced by oxidative stress. MA exhibited substantial anti-
fungal activity, especially against A. niger. The significant
antimycobacterial activity of MA may be used to prevent
complications associated with tuberculosis. These findingsindicate that MA could be an antimicrobial agent and a
promising source of natural antioxidants. However, further
studies are needed to uncover the therapeutic importance
of MA as an antioxidant, antifungal, and antimycobacterial
agent for the treatment of infectious diseases.
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